News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Millenium Biologix Inc. Enters Into Asset Sale Agreement for Skelite(TM) Technology


5/1/2007 11:18:41 AM

KINGSTON, ONTARIO -- (MARKET WIRE) -- April 30, 2007 -- Millenium Biologix Corporation ("Millenium" or the "Company") (TSX: MBC) today announced that it and its wholly-owned subsidiary Millenium Biologix Technologies Inc. ("MBTI") entered into an agreement with Medtronic of Canada Ltd. and Warsaw Orthopedic, Inc. (collectively, the "Purchasers") for the sale of MBTI's resorbable synthetic bone graft technology, Skeliteā„¢ to the Purchasers. Under the terms of the agreement, Millenium will receive a closing payment and may also subsequently receive certain milestone and contingent payments.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES